EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol.186, no.4, pp.417-427, 2022 (SCI-Expanded, Scopus)
Objective: The phenotype mediated by HNF4A/HNF1A mutations is variable and includes diazoxide-responsive hyperinsulinaemic hypoglycaemia (HH) and maturity-onset diabetes of the young (MODY).